DeLorean AI CEO Shares Insights on Predictive Medicine and the Future of Healthcare AI

Dr. Severence MacLaughlin, the founder and CEO of DeLorean AI, has been at the forefront of integrating artificial intelligence into healthcare to not just make bold claims but to save lives. Over the past six and a half years, DeLorean AI has emerged as a leader in predictive healthcare, focusing on chronic disease care with biologically validated predictions. MacLaughlin's journey from bootstrapping the company to achieving significant milestones in healthcare AI offers valuable insights into the potential of AI in transforming patient care.

One of the pivotal moments for DeLorean AI came when their technology, applied to Salesforce CRM, outperformed Salesforce’s own AI 90% of the time. This achievement was a clear indicator of the company's potential to scale and meet market demand. Further validation came when DeLorean AI's Medical AI product successfully identified Chronic Kidney Disease patients five years earlier and accurately predicted disease progression, a breakthrough confirmed by independent organizations like UnitedHealthcare and Innovative Renal Care.

MacLaughlin emphasizes the importance of demonstrating real ROI in healthcare AI, beyond just accuracy metrics. DeLorean AI's technology has shown to reduce hospitalizations by 50% within 90 days when their AI's recommendations are followed, translating to nearly $1 billion in savings for insurers and the Centers for Medicare & Medicaid Services. This practical, outcome-based approach is what sets DeLorean AI apart in a field crowded with hype.

Despite the challenges of introducing new technologies to traditionally slow-moving healthcare institutions, DeLorean AI has found success by focusing on smaller, mid-market companies that are more open to innovation. MacLaughlin's decision to bootstrap the company has also played a crucial role in shaping its disciplined approach to growth and strategic decisions, ensuring that the focus remains on building a product that truly makes a difference in patients' lives.

Looking ahead, MacLaughlin envisions DeLorean AI becoming the gold standard for quality in AI, starting with healthcare and expanding to other products. With a commitment to compliance and innovation, DeLorean AI is poised to lead the way in predictive medicine, aiming to extend patients' lives and become a household name in the process. For more information on DeLorean AI's groundbreaking work, visit https://www.delorean.ai.